Supreme Court considers taking on drug patent settlements

12/7/2012 | Bloomberg

The Supreme Court is poised to announce whether the justices will hear a case about the settlement of a lawsuit over drug patent protections. The Federal Trade Commission and the Department of Justice say such deals can violate antitrust laws, but makers of brand-name and generic drugs say the settlements are legal exercises of patent rights.

View Full Article in:

Bloomberg

Published in Brief: